Lam Research Corporation - 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Lam Research Corporation for the period ended March 25, 2001. The company manufactures semiconductor manufacturing equipment. As of the reporting date, there were 123,623,978 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Mar 25, 2001 | Nine Months Ended Mar 25, 2001 |
|---|---|---|
| Total Revenue | $421.5 million | $1,347.9 million |
| Gross Margin | $173.0 million (41.0%) | $603.2 million (44.7%) |
| Operating Income | $59.0 million | $250.8 million |
| Net Income | $44.4 million | $184.0 million |
| Diluted EPS | $0.33 | $1.36 |
| Cash & Equivalents | $190.8 million | (Balance Sheet Data) |
| Short-term Investments | $254.1 million | |
| Total Debt (Current + Long-term) | $333.0 million | (Current: $20.8M; Long-term: $312.2M) |
| Operating Cash Flow (9mo) | $173.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 29.2% for the quarter and 57.4% for the nine-month period compared to the prior year, driven by strong demand in fiscal 2000 and early fiscal 2001.
- Profitability Decline: Despite revenue growth, Net Income for the quarter decreased 33.7% ($67.0M to $44.4M) compared to the prior year quarter. This was due to a one-time restructuring recovery of $18.1M in the prior year that did not recur, and a decrease in gross margin percentage to 41.0% (from 44.4%) caused by customer shipment delays and manufacturing inefficiencies.
- Expense Increases: R&D expenses rose 28.1% and SG&A expenses rose 34.1% in absolute dollars year-over-year for the quarter, though as a percentage of revenue, R&D decreased slightly.
- Working Capital: Significant use of working capital ($121.8M) occurred due to increases in accounts receivable ($38.4M increase vs prior period balance) and inventories ($101.3M increase vs prior period balance).
Guidance, Outlook, and Risks
- Market Contraction: Management forecasts lower revenues for the next two quarters and potentially beyond due to a severe contraction in the semiconductor equipment market and customers delaying capital expenditures.
- Reduction in Force: On April 11, 2001, the company announced a plan to reduce global headcount by approximately 15% during the fourth quarter of fiscal 2001 in response to anticipated revenue declines.
- Accounting Changes: The company is assessing the impact of SEC Staff Accounting Bulletin (SAB) No. 101 on revenue recognition, which may delay revenue recognition until customer acceptance rather than shipment. Implementation is expected in the fourth quarter of fiscal 2001.
- Legal Proceedings: Ongoing patent litigation with Varian Associates and Tegal Corporation. Management does not currently believe these will have a material adverse effect, though outcomes are uncertain.
- Derivatives: The company has entered into call and put option contracts to offset dilution from convertible notes. $52.9 million related to put options has been reclassified to temporary equity.
Investor Verification Checklist
- Verify the impact of the announced 15% workforce reduction on future operating expenses and restructuring charges.
- Monitor the implementation of SAB 101 and its potential to restate prior revenue figures or delay future revenue recognition.
- Assess the sustainability of gross margins given the reported manufacturing inefficiencies and customer shipment delays.
- Review the status of the $27.5 million guaranteed residual value obligation on the new Fremont campus operating lease.
- Track the resolution of patent litigation with Varian Associates and Tegal Corporation.